Cargando…

Editorial: Cytokine Release Syndrome in COVID-19: Mechanisms and Management

Detalles Bibliográficos
Autor principal:	Hu, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9397827/ https://www.ncbi.nlm.nih.gov/pubmed/36016556 http://dx.doi.org/10.3389/fphar.2022.965714

Ejemplares similares

Therapeutic Targeting of Transcription Factors to Control the Cytokine Release Syndrome in COVID-19
por: Santoso, Clarissa S., et al.
Publicado: (2021)

Editorial: Medication Safety in COVID-19 Management
por: Das, Saibal
Publicado: (2022)

Editorial: Eicosanoids and cytokines: Resolution of inflammation
por: Liu, Jun-Yan
Publicado: (2022)

Editorial: Medication safety in COVID-19 management, Volume II
por: Das, Saibal
Publicado: (2023)

Immune Checkpoint Inhibitor-Related Cytokine Release Syndrome: Analysis of WHO Global Pharmacovigilance Database
por: Ceschi, Alessandro, et al.
Publicado: (2020)

Continuous Renal Replacement Therapy With oXiris Filter May Not be an Effective Resolution to Alleviate Cytokine Release Syndrome in Non-AKI Patients With Severe and Critical COVID-19
por: Kang, Kai, et al.
Publicado: (2022)

Cytokine Release Syndrome Is an Independent Risk Factor Associated With Platelet Transfusion Refractoriness After CAR-T Therapy for Relapsed/Refractory Acute Lymphoblastic Leukemia
por: Liu, Yadan, et al.
Publicado: (2021)

Immunotherapy Summary for Cytokine Storm in COVID-19
por: Li, Yaqun, et al.
Publicado: (2021)

Editorial: Opioids in the time of the COVID-19 pandemic: from cellular mechanisms to public health policy
por: John, Scott, et al.
Publicado: (2023)

Editorial: Herbal Medicines in Pain Management
por: Hu, Wen-Long, et al.
Publicado: (2022)

Editorial: Drug Repurposing for COVID-19 Therapy
por: Maldonado, Rafael, et al.
Publicado: (2021)

Editorial: Ulcerative colitis disease therapy: Unveiling the molecular mechanisms of well-defined composition from natural plants
por: Tao, Yi, et al.
Publicado: (2023)

Editorial: Mechanisms of Traditional Medicinal Plants Used to Control Type 2 Diabetes or Metabolic Syndrome
por: Eddouks, Mohamed, et al.
Publicado: (2021)

Editorial: Action and Mechanism of Herbal Glycans
por: Li, Shaoping, et al.
Publicado: (2022)

Editorial: Emerging mechanisms in cardiovascular disease
por: Yalcin, Huseyin C., et al.
Publicado: (2023)

Calming the Storm: Natural Immunosuppressants as Adjuvants to Target the Cytokine Storm in COVID-19
por: Peter, Angela E., et al.
Publicado: (2021)

Editorial: Understanding the Cytokine Release Syndrome: Toward Improving Cancer Immunotherapy
por: Martín-Antonio, Beatriz
Publicado: (2021)

Autoregulation of Acetylcholine Release and Micro-Pharmacodynamic Mechanisms at Neuromuscular Junction: Selective Acetylcholinesterase Inhibitors for Therapy of Myasthenic Syndromes
por: Petrov, Konstantin A., et al.
Publicado: (2018)

Editorial: Vitamin D and COVID-19: New Mechanistic and Therapeutic Insights
por: Marcinkowska, Ewa, et al.
Publicado: (2022)

Editorial: Novel Therapeutic Interventions Against Infectious Diseases: COVID-19
por: Sakkiah, Sugunadevi, et al.
Publicado: (2022)

Editorial: Myocardial Remodeling: Mechanisms and Translational Implications
por: Roncalli, Jerome, et al.
Publicado: (2022)

Drug-induced liver injury in COVID-19 treatment: Incidence, mechanisms and clinical management
por: Li, Xichuan, et al.
Publicado: (2022)

Inspiration for COVID-19 Treatment: Network Analysis and Experimental Validation of Baicalin for Cytokine Storm
por: You, Jia, et al.
Publicado: (2022)

Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19
por: Luo, Wei, et al.
Publicado: (2020)

The effect of tocilizumab on cytokine release syndrome in COVID-19 patients
por: de Cáceres, Carmen, et al.
Publicado: (2020)

Utilizing tocilizumab for the treatment of cytokine release syndrome in COVID-19
por: Hassoun, Ali, et al.
Publicado: (2020)

Anti-IL-6 Versus Anti-IL-6R Blocking Antibodies to Treat Acute Ebola Infection in BALB/c Mice: Potential Implications for Treating Cytokine Release Syndrome
por: Rubsamen, Reid, et al.
Publicado: (2020)

Systematic Review of Membrane Components of Gram-Positive Bacteria Responsible as Pyrogens for Inducing Human Monocyte/Macrophage Cytokine Release
por: Rockel, Christoph, et al.
Publicado: (2012)

Editorial: Pharmacological and biochemical perspectives of kinase inhibitors in cancer and COVID-19 therapeutics
por: Chandrasekaran, Balakumar, et al.
Publicado: (2023)

Mechanism and Management of Fentanyl-Induced Cough
por: Chen, Rong, et al.
Publicado: (2020)

Editorial: Hypertension: Novel Mechanisms of Nervous and Humoral Regulation
por: Li, Peng, et al.
Publicado: (2022)

Editorial: Molecular Mechanisms Protecting against Tissue Injury
por: Wagener, Frank A. D. T. G., et al.
Publicado: (2016)

Editorial: Neuropharmacological, Neurobiological and Behavioral Mechanisms of Learning and Memory
por: Meneses, Alfredo, et al.
Publicado: (2019)

Editorial: Mechanisms and New Targets for the Treatment of Chronic Pain
por: Nieto, Francisco Rafael, et al.
Publicado: (2020)

Editorial: Alzheimer’s Disease: Original Mechanisms and Translational Impact
por: Mancuso, Cesare, et al.
Publicado: (2020)

Editorial: Molecular Mechanisms of Voltage-Gating in Ion Channels
por: Loussouarn, Gildas, et al.
Publicado: (2021)

The therapeutic effect and mechanism of parthenolide in skeletal disease, cancers, and cytokine storm
por: Zhu, Sipin, et al.
Publicado: (2023)

Editorial: IBD Management—Novel Targets and Therapeutic Perspectives
por: Antonioli, Luca, et al.
Publicado: (2020)

Editorial: Traditional medicine bioactives for management of diabetes mellitus
por: Khanal, Pukar, et al.
Publicado: (2023)

Targeting Cytokine Release Through the Differential Modulation of Nrf2 and NF-κB Pathways by Electrophilic/Non-Electrophilic Compounds
por: Fagiani, Francesca, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kcee2cdl0ht83kjg9krtemqea1